story of the week
Alectinib for Resected ALK-Positive NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
N. Engl. J. Med 2024 Apr 11;390(14)1265-1276, YL Wu, R Dziadziuszko, JS Ahn, F Barlesi, M Nishio, DH Lee, JS Lee, W Zhong, H Horinouchi, W Mao, M Hochmair, F de Marinis, MR Migliorino, I Bondarenko, S Lu, Q Wang, T Ochi Lohmann, T Xu, A Cardona, T Ruf, J Noe, BJ SolomonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.